Results 81 to 90 of about 22,658,601 (368)

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker   +11 more
wiley   +1 more source

Highlights in this issue

open access: yesActa paediatrica, 2018
In this month’s issue of HPB I am pleased to see two articles which address the topic of the heterogeneity of the data reported in the literature. Both focus on the use of definitions of variables or outcomes as well as the lack of standardisation of ...
A. Käll, H. Lagercrantz
semanticscholar   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

LIST OF RHEUMATOLOGY MEASURES IN 2015

open access: yesНаучно-практическая ревматология, 2015
.
Issue Editor
doaj   +2 more sources

Vol 10 No 1 (2020)

open access: yesProfessions and Professionalism, 2020
Issue Issue
doaj   +1 more source

In This Issue

open access: yesJournal of MultiDisciplinary Evaluation, 2005
This is a particularly exciting issue, for several reasons. First, we have an important paper by Tom Cook (describing what is special about the role of experiments, etc.) which goes a long way towards defining a compromise on the ‘causal wars’ issues, as I try to spell out in a few comments, and Jane Davidson discusses in her editorial.
openaire   +6 more sources

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

Entire issue

open access: yesJournal of Problem Based Learning in Higher Education, 2023
Full issue
doaj   +1 more source

Home - About - Disclaimer - Privacy